| Name | 1-cyclohexyloxycarbonyloxyethyl 2-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-benzimidazole-4-carboxylate |
|---|---|
| Synonyms |
Candestan Cilexetil Impurity 2 Impurity B)
Candestan Impurity II 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate Candestan Cilexetil Impurity Ⅱ 2,3-Dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester Candestan Impurity B Candestan Cilexetil ImpuritⅠ: O-Desethyl Candestan Cilexetil( 2,3-Dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-cboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester) 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 3-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-cboxylate Candestan Cilexetil Impurity B (Candestan Cilexetil O-Desethyl Analog) 2,3-Dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]-1H-benziMidazole-4-cboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester Candestan Imp B Candestan Cilexetil IMpurity B 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2,3-dihydro-2-oxo-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-cboxylate 1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 3-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-cboxylate (Candestan cilexetil Impurity) 1-(((cyclohexyloxy)carbonyl)oxy)ethyl 3-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl) -2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-cboxylate Candestan Cilexetil Impurity 2(Candestan Cilexetil Impurity B) desethyl-condesartan 2-oxocandesartan cilexetil Candestan Cilexetil O-Desethyl Analog Candestan Cilexetil ImpuritⅠ: O-Desethyl Candestan Cilexetil( 2,3-Dihydro-2-oxo-3-[[2’-(2H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-cboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester) Candestan Cilexetil Imp. B : (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo- 3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H- benzimidazole-4-cboxylate O-Desethyl Candesartan Cilexetil Candestan Cilexetil impurity BQ: What is Candestan Cilexetil impurity B Q: What is the CAS Number of Candestan Cilexetil impurity B Q: What is the storage condition of Candestan Cilexetil impurity B Q: What e the applications of Candestan Cilexetil impurity B O-Desethyl Candestan Cilexetil Candestan Cilexetil Impurity B (Desethyl Candestan Cilexetil) 1-(Cyclohexyloxycbonyloxy)ethyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl) methyl)-2-hydroxy-1H-benzo[d]imidazole-7-cboxylate Candestan cilexetil impurity II (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H- tetrazol-5-yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4- cboxylate Candestan Impurity 1 CNS-desethyl 1H-Benzimidazole-4-cboxylic acid, 2,3-dihydro-2-oxo-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester Candestan Cilexetil Related Compound B (1-(Cyclohexyloxycbonyloxy)ethyl 1-{[2''-(1H- tetrazol-5 Candesartan Cilexetil Impurity 2 (1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 2-Oxo-3-[[2'-(1H-tetrazol-5-yl-)-biphenyl-4-yl]methyl] 1-cyclohexyloxycbonyloxyethyl 2-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-benzimidazole-4-cboxylate candestan cilexetil impurity1358 desethyl-CNS UNII-JC6R5VA63B Candestan Cilexetil Related Compound B |
| Molecular Formula | C31H30N6O6 |
|---|---|
| Molecular Weight | 582.60600 |
| Exact Mass | 582.22300 |
| PSA | 154.34000 |
| LogP | 5.62600 |
| RIDADR | NONH for all modes of transport |
|---|
|
~%
869631-11-8 |
| Literature: KRKA, D.D. NOVO MESTO Patent: WO2007/42161 A1, 2007 ; Location in patent: Page/Page column 16-17 ; |
|
~88%
869631-11-8 |
| Literature: Havllcek, Jaroslav; Mandelova, Zuzana; Weisemann, Ruediger; Strelec, Ivo; Placek, Lukas; Radl, Stanislav Collection of Czechoslovak Chemical Communications, 2009 , vol. 74, # 2 p. 347 - 362 |
|
~70%
869631-11-8 |
| Literature: Havllcek, Jaroslav; Mandelova, Zuzana; Weisemann, Ruediger; Strelec, Ivo; Placek, Lukas; Radl, Stanislav Collection of Czechoslovak Chemical Communications, 2009 , vol. 74, # 2 p. 347 - 362 |
|
~%
869631-11-8 |
| Literature: TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ; |
|
~%
869631-11-8 |
| Literature: TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2006/122254 A2, 2006 ; Location in patent: Page/Page column 12; 13 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |